Guidance Document: Data Protection under C.08.004.1 of the Food and Drug Regulations
Canada’s obligations under the North American Free Trade Agreement and the Agreement on Trade-Related Aspects of Intellectual Property Rights require the granting of protection for undisclosed test or other data necessary to determine the safety and effectiveness of a pharmaceutical product which utilizes a new chemical entity, the origination of which involved considerable effort.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2021-07-05
Data overview
- Formats
- HTML
- File languages
- English, French